Furuya-Kanamori L, Gyawali N, Mills DJ, Hugo LE, Devine GJ, Lau CL. The Emergence of Japanese Encephalitis in Australia and the Implications for a Vaccination Strategy. TropicalMed. 2022 May 29;7(6):85.
March 2022Islam N, Lau C, Leeb A, Mills D, Furuya-Kanamori L. Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. Human Vaccines & Immunotherapeutics. 2022 Mar 7;1–8.
December 2021
Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis. Journal of Travel Medicine. 2021 Dec 7;taab188.
December 2021 Mills DJ, Ramsey L, Furuya-Kanamori L. Pre- and Post-Travel Medical Consultations. In: Wilks J, Pendergast D, Leggat PA, Morgan D, editors. Tourist Health, Safety and Wellbeing in the New Normal [Internet]. Singapore: Springer Singapore; 2021 [cited 2021 Dec 2]. p. 47–69. Available from:
December 2021 Lau CL, Mayfield HJ, Sinclair JE, Brown SJ, Waller M, Enjeti AK, et al. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine. 2021 Dec;39(51):7429–40.
September 2021Furuya-Kanamori L, Mills DJ, Trembizki E, Robson JM, Jennison AV, Whiley DM, et al. High rate of asymptomatic colonization with antimicrobial-resistant Escherichia coli in Australian returned travellers. Journal of Travel Medicine. 2021 Sep 7;taab141.
July 2021Ling W, Doi SAR, Lau CL, Mills DJ, Kostoulas P, Furuya-Kanamori L. Diagnostic accuracy of ELISA kits for measurement of rabies antibodies. Journal of Travel Medicine. 2021 Jul 7;28(5):taab060.
June 2021 Furuya-Kanamori L, Xu C, Doi SAR, Clark J, Wangdi K, Mills DJ, et al. Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine. 2021 Jun;S0264410X21007593.
April 2021Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers.Journal of Travel Medicine. 2021 Apr 10;taab059.
April 2021Islam N, Wright S, Lau CL, Doi SAR, Mills DJ, Clark J, et al. Efficacy of a 3-day pre-travel schedule of Tafenoquine for malaria chemoprophylaxis: A network meta-analysis. Journal of Travel Medicine. 2021 Apr 8;taab057.
January 2021Xu C, Lau CL, Clark J, Rafferty AC, Mills DJ, Ramsey L, et al. Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis.Vaccine [Internet]. 2021 Jan 18 [cited 2021 Jan 19]; Available from:
December 2020Mills DJ, Lau CL, Furuya-Kanamori L. Low uptake of Japanese encephalitis vaccination among Australian travellers.Journal of Travel Medicine [Internet]. 2020 Dec 12 [cited 2021 Jan 4]; Available from:
September 2020Furuya-Kanamori L, Mills DJ, Lau CL. Could intradermal be an economical alternative route of administration for Japanese encephalitis vaccines? Journal of Travel Medicine [Internet]. 2020 Sep 29 [cited 2020 Nov 6]; Available from:
April 2020Furuya-Kanamori L, Dutton P, Leeb A, Mills DJ, Andrews R, Lau CL. Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children. Journal of the Pediatric Infectious Diseases Society [Internet]. 2020 Apr 25 [cited 2021 Jan 7]; Available from:
April 2020Furuya-Kanamori L, Lau CL, Banks S, Mills DJ. Impact of pre-departure preparation on the health and wellbeing of Australian gap year travellers.Travel Medicine and Infectious Disease. 2020 Apr;101682.
January 2020Furuya-Kanamori L, Ramsey L, Manson M, Gilbert B, Lau CL. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster. Journal of Travel Medicine [Internet]. 2020 Jan 14 [cited 2020 Jan 18]; Available from:
November 2019Furuya-Kanamori L, Stone J, Yakob L, Kirk M, Collignon P, Mills DJ, et al. Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: A synthesis of cumulative evidence. Journal of Travel Medicine [Internet]. 2019 Nov 6 [cited 2020 Jan 22]; Available from:
September 2019Wang J, Liu-Lastres B, Ritchie BW, Mills DJ. Travellers’ self-protection against health risks:An application of the full Protection Motivation Theory. Annals of Tourism Research. 2019 Sep;78:102743.
May 2019Lau CL, Sweet M, Weinstein P. A stitch in time: unrecognized retained foreign bodies after a needlefish injury.Journal of Travel Medicine [Internet]. 2017 Mar 1 [cited 2019 May 19];24(2). Available from:
April 2019Aubry M, Kama M, Vanhomwegen J, Teissier A, Mariteragi-Helle T, Hue S, C Lau, et al. Ross River Virus Antibody Prevalence, Fiji Islands, 2013–2015. Emerging Infectious Diseases. 2019 Apr;25(4):827–30.
January 2019Armstrong M, Francis J, Robson J, Graves S, Mills DJ, Ferguson J, et al. Q fever vaccination of children in Australia: Limited experience to date: Q fever vaccination in Australia.Journal of Paediatrics and Child Health [Internet]. 2019 Jan 2 [cited 2019 Jan 7];
October 2018Ritter JM, Lau C, Craig SB, Goarant C, Nilles EJ, Ko AI, et al. A Large Leptospirosis Outbreak following Successive Severe Floods in Fiji, 2012. The American Journal of Tropical Medicine and Hygiene. 2018 Oct 3;99(4):849–51.
October 2018Lau CL, Ramsey L, Mills L, Furuya-Kanamori L, Mills DJ. Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers. Clinical Infectious Diseases [Internet]. 2018 Oct 3 [cited 2018 Oct 4];
April 2018Flies EJ, Lau CL, Carver S, Weinstein P. Another Emerging Mosquito-Borne Disease? Endemic Ross River Virus Transmission in the Absence of Marsupial Reservoirs. BioScience. 2018 Apr 1;68(4):288–93.
March 2018Jelinek T, Cromer MA, Cramer JP, Mills D et al. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO ® , JESPECT ® ) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study. Travel Medicine and Infectious Disease. March 2018. doi:10.1016/j.tmaid.2018.03.003
2017Furuya-Kanamori L, Mills D, Sheridan S, Lau C. Medical and psychological problems faced by young Australian gap year travellers‡. J Travel Med. 2017;24(5). doi:10.1093/jtm/tax052.
April 2017Lau C, Aubry M, Musso D, Teissier A, Paulous S, Desprès P, et al. New evidence for endemic circulation of Ross River virus in the Pacific Islands and the potential for emergence. International Journal of Infectious Diseases. 2017 Apr;57:73–6.
April 2017Huang X, Lambert S, Lau C, Soares Magalhaes RJ, Marquess J, Rajmokan M, et al. Assessing the social and environmental determinants of pertussis epidemics in Queensland, Australia: a Bayesian spatio-temporal analysis. Epidemiology and Infection. 2017 Apr;145(6):1221–30.
February 2016Lau CL, Streeton CL, David MC, Sly PD, Mills DJ. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2–16 years: an observational study. Journal of Travel Medicine. 2016 Feb 1;23(2):tav023.
2016Mills, D.J.,Kohl, S.E., 2016. Twitter for travel medicine providers. Journal of Travel Medicine 23, taw002. doi:10.1093/jtm/taw002
November 2015David MC, Ha SH, Paynter S, Lau C. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. Vaccine. 2015 Nov;33(48):6564–9.
March 2015Derne B, Weinstein P, Musso D, Lau C. Distribution of rickettsioses in Oceania: Past patterns and implications for the future. Acta Tropica. 2015 Mar;143:121–33.
2015Martin-Blondel, G., Iriart, X., Baidouri, F. El, Simon, S., Mills, D., Demar, M., Pistone, T., Le Taillandier, T., Malvy, D., Gangneux, J.-P., Couppie, P., Munckhof, W., Marchou, B., Ravel, C., Berry, A., 2015. Outbreak of Leishmania braziliensisCutaneous Leishmaniasis, Saül, French Guiana. Emerging Infectious Diseases 21, 892–894. doi:10.3201/eid2105.1411811.
Lau CL, Weinstein P, Slaney D. Dengue surveillance by proxy: travellers as sentinels for outbreaks in the Pacific Islands. Epidemiology and Infection. 2013 Nov;141(11):2328–34.
Lau CL, Hohl N. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: An observational study. Travel Medicine and Infectious Disease. 2013 Nov;11(6):427–30.
2013Mills, D., 2013. Intradermal pre-exposure rabies vaccination. Promises and pitfalls. Travel Medicine and Infectious Disease 11, 335–336. doi:10.1016/j.tmaid.2013.10.007
Lau C, Weinstein P, Slaney D. Imported cases of Ross River virus disease in New Zealand – A travel medicine perspective.Travel Medicine and Infectious Disease. 2012 May;10(3):129–34.
2011Mills, D.J., Lau, C.L., Fearnley, E.J., Weinstein, P., 2011. The Immunogenicity of a Modified Intradermal Pre-exposure Rabies Vaccination Schedule—A Case Series of 420 Travelers. Journal of Travel Medicine 18, 327–332.
2011Mills, D.J., Lau, C.L., Weinstein, P., 2011. Animal bites and rabies exposure in Australian travellers. Med. J. Aust. 195, 673–675.
January 2010Lau C, Smythe L, Weinstein P. Leptospirosis: An emerging disease in travellers. Travel Medicine and Infectious Disease. 2010 Jan;8(1):33–9.
2007Leggat, P.A., Mills, D., Speare, R., 2007. Level of Concern and Sources of Information of a Group of Brisbane Hostelers for Personal Safety and Terrorism When Traveling Abroad.Journal of Travel Medicine 14, 112–116.
March 2006Lau C, Sisson J. The Effectiveness of Intradermal Pre-exposure Rabies Vaccination in an Australian Travel Medicine Clinic. Journal of Travel Medicine. 2006 Mar 8;9(6):285–8.
1993Mulhall, B.P., Hu, M., Thompson, M., Lin, F., Lupton, D., Mills, D., Maund, M., Cass, R., Millar, D., 1993. Planned sexual behaviour of young Australian visitors to Thailand. Med. J. Aust. 158, 530–535.